Description
Infragyl Spag Peca Oral Drops 30 ml Vial
Composition
Infragyl Spag Peca Oral Drops contain the active ingredient Metronidazole, an antibiotic that fights bacteria in the body.
Mechanism of Action
Metronidazole works by entering bacterial cells and interfering with their DNA, leading to bacterial death. It is particularly effective against anaerobic bacteria that thrive in low oxygen environments.
Pharmacological Properties
Metronidazole exhibits bactericidal activity by disrupting DNA synthesis in susceptible organisms. It is well-absorbed orally and widely distributed in body tissues, including the central nervous system.
Indications for Use
Infragyl Spag Peca Oral Drops are indicated for the treatment of bacterial infections, including specific types of vaginal and skin infections caused by susceptible organisms.
Contraindications
Do not use Infragyl Spag Peca Oral Drops if you have a known allergy to metronidazole or any other components of the product. Consult your healthcare provider before starting treatment to discuss any allergies or medical conditions.
Side Effects
Common side effects of Metronidazole may include nausea, vomiting, diarrhea, and metallic taste in the mouth. Serious side effects such as allergic reactions or neurological effects are rare but possible.
Usage Instructions
Before use, shake the vial well. Take the prescribed oral drops as directed by your healthcare provider. Adhere to the recommended dosage and duration of treatment to ensure optimal therapeutic outcomes.
Benefits Compared to Analogues
Infragyl Spag Peca Oral Drops offer the advantage of targeted antibiotic therapy with Metronidazole, known for its efficacy against a wide range of bacterial infections, including anaerobic pathogens.
Suitable Patient Groups
This medication is suitable for adults, including the elderly, and adolescents under medical supervision. Use in children should be determined by a healthcare provider based on individual considerations.
Storage and Shelf Life
Store Infragyl Spag Peca Oral Drops at room temperature away from moisture and heat. Check the product packaging for the expiration date and follow proper disposal guidelines after use.
Packaging Description
The product is supplied in a 30 ml vial for oral administration. The packaging should include clear instructions for use, dosage information, and precautions.
Clinical Evidence and Proven Effectiveness
Studies have demonstrated the efficacy of Metronidazole in treating various bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy highlighted its effectiveness against anaerobic infections. Additionally, a study in the International Journal of Antimicrobial Agents supported its use in Clostridium difficile infections.
